PhaseV
Brad Carlin is an accomplished statistician and public health expert with extensive experience in academia and consulting. Currently serving as a member of the Scientific Advisory Board at PhaseV and as a Senior Advisor in Data Science and Statistics at PharmaLex, Brad is also the Founder and President of Counterpoint Statistical Consulting, LLC. Previous positions include Mayo Professor in Public Health, Professor of Biostatistics, and Head of the Division of Biostatistics at the University of Minnesota School of Public Health, as well as Visiting Assistant Professor of Statistics at Carnegie Mellon University. Brad holds a Doctor of Philosophy in Statistics from the University of Connecticut and a Bachelor of Science in Mathematics and Actuarial Science from the University of Nebraska-Lincoln.
This person is not in any teams
This person is not in any offices
PhaseV
PhaseV develops a platform for adaptive trial design and closed-loop execution, leveraging an intuitive user interface and flexible software architecture along with cutting-edge algorithms such as reinforcement learning and causal ML to support key clinical decisions at any point during the trial